UBS AM’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-353,508
| Closed | -$261K | – | 2677 |
|
|
2024
Q4 | $261K | Buy |
353,508
+233,121
| +194% | +$281K | ﹤0.01% | 2620 |
|
|
2024
Q3 | $189K | Buy |
+120,387
| New | +$214K | ﹤0.01% | 2763 |
|
|
2023
Q4 | – | Sell |
-137,735
| Closed | -$150K | – | 2576 |
|
|
2023
Q3 | $150K | Hold |
137,735
| – | – | ﹤0.01% | 2542 |
|
|
2023
Q2 | $335K | Hold |
137,735
| – | – | ﹤0.01% | 2441 |
|
|
2023
Q1 | $335K | Buy |
137,735
+18,689
| +16% | +$42.8K | ﹤0.01% | 2441 |
|
|
2022
Q4 | $227K | Hold |
119,046
| – | – | ﹤0.01% | 2412 |
|
|
2022
Q3 | $286K | Sell |
119,046
-56,904
| -32% | -$157K | ﹤0.01% | 2505 |
|
|
2022
Q2 | $327K | Buy |
175,950
+92,076
| +110% | +$176K | ﹤0.01% | 2448 |
|
|
2022
Q1 | $175K | Hold |
83,874
| – | – | ﹤0.01% | 2698 |
|
|
2021
Q4 | $330K | Hold |
83,874
| – | – | ﹤0.01% | 2659 |
|
|
2021
Q3 | $403K | Buy |
83,874
+7,499
| +10% | +$30.8K | ﹤0.01% | 2561 |
|
|
2021
Q2 | $351K | Buy |
+76,375
| New | +$368K | ﹤0.01% | 2620 |
|
|
2020
Q2 | – | Sell |
-48,341
| Closed | -$94.3K | – | 2504 |
|
|
2020
Q1 | $94.3K | Sell |
48,341
-1,063,307
| -96% | -$3.17M | ﹤0.01% | 2399 |
|
|
2019
Q4 | $4.61M | Sell |
1,111,648
-7,552
| -0.7% | -$29.1K | ﹤0.01% | 1223 |
|
|
2019
Q3 | $3.37M | Buy |
1,119,200
+4,669
| +0.4% | +$14.5K | ﹤0.01% | 1372 |
|
|
2019
Q2 | $7.01M | Hold |
1,114,531
| – | – | 0.01% | 1076 |
|
|
2019
Q1 | $6.2M | Sell |
1,114,531
-1,827,892
| -62% | -$11.1M | ﹤0.01% | 1077 |
|
|
2018
Q4 | $19.5M | Sell |
2,942,423
-861,605
| -23% | -$6.98M | 0.02% | 711 |
|
|
2018
Q3 | $40.6M | Sell |
3,804,028
-170,868
| -4% | -$1.96M | 0.03% | 563 |
|
|
2018
Q2 | $47.7M | Sell |
3,974,896
-38,377
| -1% | -$393K | 0.04% | 513 |
|
|
2018
Q1 | $34.4M | Sell |
4,013,273
-147,199
| -4% | -$1.36M | 0.03% | 618 |
|
|
2017
Q4 | $41.1M | Buy |
4,160,472
+582,922
| +16% | +$6.06M | 0.03% | 515 |
|
|
2017
Q3 | $44M | Sell |
3,577,550
-235,952
| -6% | -$3.48M | 0.04% | 467 |
|
|
2017
Q2 | $62.7M | Sell |
3,813,502
-275,917
| -7% | -$4.27M | 0.06% | 352 |
|
|
2017
Q1 | $58.6M | Sell |
4,089,419
-31,090
| -0.8% | -$461K | 0.06% | 349 |
|
|
2016
Q4 | $57M | Sell |
4,120,509
-670,472
| -14% | -$10.8M | 0.06% | 333 |
|
|
2016
Q3 | $86.6M | Sell |
4,790,981
-1,779,731
| -27% | -$28.6M | 0.09% | 240 |
|
|
2016
Q2 | $94.3M | Sell |
6,570,712
-651,006
| -9% | -$8.83M | 0.11% | 207 |
|
|
2016
Q1 | $86.3M | Sell |
7,221,718
-1,230,797
| -15% | -$12.9M | 0.1% | 229 |
|
|
2015
Q4 | $113M | Buy |
8,452,515
+63,395
| +0.8% | +$779K | 0.13% | 178 |
|
|
2015
Q3 | $90.1M | Buy |
8,389,120
+1,915,446
| +30% | +$20.9M | 0.1% | 227 |
|
|
2015
Q2 | $52.1M | Buy |
6,473,674
+1,002,004
| +18% | +$7.36M | 0.05% | 403 |
|
|
2015
Q1 | $36.2M | Buy |
5,471,670
+551,850
| +11% | +$3.77M | 0.03% | 516 |
|
|
2014
Q4 | $31.3M | Buy |
4,919,820
+1,565,652
| +47% | +$12.6M | 0.03% | 576 |
|
|
2014
Q3 | $33.1M | Buy |
3,354,168
+571,580
| +21% | +$6.1M | 0.03% | 545 |
|
|
2014
Q2 | $31.4M | Buy |
2,782,588
+69,846
| +3% | +$750K | 0.03% | 556 |
|
|
2014
Q1 | $32.9M | Buy |
2,712,742
+164,603
| +6% | +$2.1M | 0.04% | 515 |
|
|
2013
Q4 | $32.1M | Buy |
2,548,139
+535,232
| +27% | +$8.52M | 0.04% | 484 |
|
|
2013
Q3 | $33.4M | Buy |
2,012,907
+708,916
| +54% | +$11.9M | 0.04% | 441 |
|
|
2013
Q2 | $19.8M | Buy |
+1,303,991
| New | +$19.8M | 0.03% | 576 |
|
Other funds holding LXRX
AG
SL
SSA
